Trade RCEL anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Avita Medical, Inc. (RCEL) is trading at US$11.20, up 2.38% today as of Sep 4, 16:00 EDT. The company has a market capitalisation of US$311.12M. Over the past 52 weeks, RCEL has traded between US$3.22 and US$11.39. On Syfe you can trade RCEL with $0 commission and add it to your watchlist.
| Previous close | US$10.94 |
|---|---|
| Market cap | US$311.12M |
| 52-week range | US$3.22 – US$11.39 |
| Volume | 301.6K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Avita Medical, Inc.
AVITA Medical, Inc., through its subsidiaries, engages in the development and commercialization of a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs. Its product, RECELL system, is a device that enables healthcare professionals to produce a suspension of spray-on skin cells using a small sample of the patient's own skin for the treatment of acute thermal burns. The company was founded in December 1992 and is headquartered in Valencia, CA.
Year: 2012
AVITA Medical Q1 Loss Narrows, Revenue Rises; 2026 Revenue Guidance Reaffirmed
May 14, 8:36 PM · MT Newswires
AVITA Medical Names Cary Vance as CEO
Apr 30, 2:48 PM · MT Newswires
Avita Medical Signs 10-Year BARDA Agreement Valued Up to $25.5 Million
Apr 8, 8:36 PM · MT Newswires
Avita Medical, Inc. (RCEL) stock is trading at US$11.20, +2.38% from the previous close of US$10.94.
The market cap for Avita Medical, Inc. (RCEL) stock is approximately US$311.12M.
The 52-week high for Avita Medical, Inc. (RCEL) stock is US$11.39.
The 52-week low for Avita Medical, Inc. (RCEL) stock is US$3.22.
Avita Medical, Inc. (RCEL) does not currently pay a dividend.
Stay on top of RCEL
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
